Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06828822
NA

CongenItal Naevus Cohort for Longitudinal Evaluation

Sponsor: Nantes University Hospital

View on ClinicalTrials.gov

Summary

Congenital Nevus (CN) is a pigmented skin lesion present at birth, which grows in size as the child grows. It can vary in appearance and is classified by its size, from small (less than 1.5 cm) to giant (greater than 40 cm). CN is associated with genetic mutations, mainly in the NRAS/BRAF genes. A large CN can lead to several clinical issues, including: Risk of neurological disorders: Large CN can be associated with neurological abnormalities such as neuro-meningeal melanosis, hydrocephalus, or brain malformations. These conditions may cause early neuro-developmental delays. The risk is not well understood and requires further studies. Risk of melanoma: The risk of developing melanoma is higher for a large CN but remains low for smaller ones. Increased monitoring is necessary during the early years for large and giant CN. Psycho-social impact: Parents often experience significant anxiety at birth due to the cancer risk and social stigma. As the child grows, a visible CN may impact their quality of life, particularly socially at school. Management of CN remains controversial, especially for those of medium to giant size or with multiple satellites. There is an urgent need for further research to clarify best practices in monitoring and treatment, including the need for routine brain imaging and criteria for surgical intervention. Ultimately, this study aims to deepen our understanding of CN, its associated neurological and melanoma risks, and the psycho-social challenges it poses, while striving to establish clear, evidence-based guidelines for monitoring and treatment to enhance patient outcomes and quality of life.

Official title: CIRCLE : CongenItal Naevus Cohort for Longitudinal Evaluation

Key Details

Gender

All

Age Range

0 Years - 24 Months

Study Type

INTERVENTIONAL

Enrollment

819

Start Date

2025-07-23

Completion Date

2031-07-23

Last Updated

2026-03-09

Healthy Volunteers

No

Interventions

OTHER

Neurodevelopmental assessment

This assessment will be conducted using the ASQ-3 test. (ASQ-3 stands for Ages and Stages Questionnaires, Third Edition, which is a common screening tool for evaluating developmental progress in young children.)

OTHER

Meeting with the parents

This meeting will evaluate the parents' acceptance of the lesion and their quality of life using the MARKS test (Measure of Acceptance of Skin Marks). The results will provide insights into how the parents perceive the lesion and how it impacts their daily lives.

OTHER

Patient quality of life assessment

Collection of patient quality of life data

Locations (16)

Grasse Hospital

Nice, Alpes-Maritimes, France

Nice University Hospital and Lenval Hospital

Nice, Alpes-Maritimes, France

Marseille University Hospital

Marseille, Bouches-du-Rhône, France

Dijon University Hospital

Dijon, Côte-d'Or, France

La Réunion University Hospital

La Réunion, Département Et Région d'Outre-mer, France

Brest University Hospital

Brest, Finistère, France

Bordeaux University Hospital

Bordeaux, Gironde, France

Toulouse University Hospital

Toulouse, Haute-Garonne, France

Rennes University Hospital

Rennes, Ille-et-Vilaine, France

Tours University Hospital

Tours, Indre-et-Loire, France

Nantes University Hospital

Nantes, Loire Atlantique, France

Angers University Hospital

Angers, Maine et Loire, France

Nancy University Hospital

Nancy, Meurthe-et-Moselle, France

Saint Vincent de Paul Hospital

Lille, Nord, France

Paris Necker Hospital

Paris, Paris, France

CHU Lille

Lille, France